We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Cosmetic Surgery of the Forehead Could Ease Migraine Pain

By HospiMedica International staff writers
Posted on 08 Sep 2009
Surgical deactivation of three common migraine-headache trigger sites via a forehead cosmetic lift could help patients with migraines that are difficult to manage with standard protocols.

Researchers from Case Western Reserve University (Cleveland, OH, USA) conducted a double blind, controlled clinical trial involving 75 patients with moderate to severe migraine headache, who met International Classification of Headache Disorders II criteria. More...
Frontal, temporal, and occipital trigger sites were identified, and the patients were randomly assigned to receive either actual or sham surgery in their predominant trigger site. The patients completed the Migraine Disability Assessment, Migraine-Specific Quality of Life, and Medical Outcomes Study 36-Item Short Form Health Survey health questionnaires before treatment, and again at one-year follow-up.

The study results showed that 57.7% of the control group and 83.7% of the surgery group experienced at least 50% reduction in migraine headache; furthermore, 57.1% of the patients in the surgery group reported complete elimination of migraine headache, compared to only one of 26 patients in the sham surgery group (3.8%). Compared with the control group, the actual surgery group demonstrated statistically significant improvements in all validated migraine headache measurements at one year; these improvements were not dependent on the trigger site. The most common surgical complication was slight hollowing of the temple in the group with temporal migraine headache. The study was published in the August 2009 issue of the journal Plastic and Reconstructive Surgery.

"A certain degree of skepticism is healthy,” said lead author Bahman Guyuron, M.D., of the department of plastic surgery. "But there's no question in my mind we are seeing results, and patients are experiencing an enduring positive response.”

Related Links:

Case Western Reserve University




Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Pressure Guidewire
SavvyWire
Mammo DR Retrofit Solution
DR Retrofit Mammography
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.